GeneDx Holdings Corp. (NASDAQ: WGS) reported Q2 EPS of ($1.84), $1.74 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $48.71 million versus the consensus estimate of $52.76 million.

For earnings history and earnings-related data on GeneDx Holdings Corp. (WGS) click here.